EUVIMEDOntdek EUVIMED
Open access · CC BY 4.0

Quality of life in diverticulosis across different clinical manifestations: Findings from the DIVIPACT cohort including 19,244 patients

Helene R Dalby iD, Rune Erichsen iD, Katrine J Emmertsen iD

Colorectal Disease · 2026-11 · 28 (11)

DOI: 10.1111/codi.70681 ↗

At a glance

Journal article in Colorectal Disease, published online on 2026-11-12. Written by Helene R Dalby and 2 co-authors. Institution: Department of Clinical Medicine, University Clinic for Coloproctology and Endoscopy (U-COPE), Aarhus University, Aarhus, Denmark. Major MEDLINE topics: Quality of Life. 28 references. The full text is freely available (open access, CC BY 4.0). Funded by: Novo Nordisk Fonden.

SamenvattingSubjectsBibliografische gegevensCiteRelated studies

Abstract (original language)

Aim

This study aimed to examine disease‐specific quality of life (QoL) among individuals with diverticulosis across different clinical manifestations and identify characteristics associated with an unacceptable symptom burden.

Method

This was a population‐based study within the DIVIPACT cohort, linking cross‐sectional questionnaire data collected in 2023 with Danish health registry data collected from 2010 to 2024. The DIVIPACT cohort comprises 19,244 subjects diagnosed with diverticulosis (K572‐9) in the Central Denmark Region (~1.3 million residents) from 2010 to 2022. Respondents were classified into mutually exclusive groups according to prior hospital management for diverticulosis (emergency resection, elective resection, laparoscopic lavage, inpatient, outpatient or diverticulosis only as a secondary diagnosis) and characterised based on registry and self‐reported data. QoL was evaluated using the Diverticular Disease Quality of Life (DV‐QoL) instrument.

Results

The total DV‐QoL was completed by 17,056 respondents (89% of all). An unacceptable symptom burden (i.e. total DV‐QoL score ≥3.2) was reported by 53% of patients in the emergency resection group, 62% in the elective resection group, 42% in the laparoscopic lavage group, 42% in the inpatient group, 32% in the outpatient group, and 24% in the diverticulosis group. Female sex, younger age and reduced self‐rated performance status were associated with an unacceptable symptom burden. Compared with the diverticulosis group, all hospital‐managed groups demonstrated higher odds of an unacceptable symptom burden.

Conclusion

Diverticular disease is associated with a substantial symptom burden that extends beyond acute clinical episodes and is not fully captured by traditional disease classifications. Demographic and functional factors play a central role in perceived disease burden.

Subjects

MeSH terms (MEDLINE)

Quality of LifeHumansFemaleMaleMiddle AgedCross-Sectional StudiesAgedDenmarkSymptom BurdenSurveys and QuestionnairesAdultRegistriesAged, 80 and overCohort Studies

Author keywords

diverticular diseasediverticulitisdiverticulosisquality of liferegistry datasurvey

Authors and institutions

  • Department of Clinical Medicine, University Clinic for Coloproctology and Endoscopy (U-COPE), Aarhus University, Aarhus, Denmark.
  • Department of Surgery, Viborg Regional Hospital, Viborg, Denmark.
  • Department of Surgery, Randers Regional Hospital, Randers, Denmark.

ORCID profiles: Helene R Dalby, Rune Erichsen, Katrine J Emmertsen

Funding

  • Novo Nordisk Fonden

Cite

APA

Dalby, H. R., Erichsen, R., & Emmertsen, K. J. (2026). Quality of life in diverticulosis across different clinical manifestations: Findings from the DIVIPACT cohort including 19,244 patients. Colorectal Disease, 28(11). https://doi.org/10.1111/codi.70681

Vancouver

Dalby HR, Erichsen R, Emmertsen KJ. Quality of life in diverticulosis across different clinical manifestations: Findings from the DIVIPACT cohort including 19,244 patients. Colorectal Disease. 2026;28(11). doi:10.1111/codi.70681

BibTeX
@article{Dalby2026,
  author = {Dalby, Helene R and Erichsen, Rune and Emmertsen, Katrine J},
  title = {Quality of life in diverticulosis across different clinical manifestations: Findings from the DIVIPACT cohort including 19,244 patients},
  journal = {Colorectal Disease},
  year = {2026},
  volume = {28},
  number = {11},
  doi = {10.1111/codi.70681}
}
Start for free →